Abstract
As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Anti-Infective Agents
Title:Avian Flu; Pathogenesis and Therapy
Volume: 10 Issue: 2
Author(s): Da-Yong Lu, Ting-Ren Lu and Hong-Ying Wu
Affiliation:
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Abstract: As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Export Options
About this article
Cite this article as:
Lu Da-Yong, Lu Ting-Ren and Wu Hong-Ying, Avian Flu; Pathogenesis and Therapy, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020124
DOI https://dx.doi.org/10.2174/2211362611208020124 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery New Insights on the Perturbations of T Cell Cycle During HIV Infection
Current Medicinal Chemistry Toll-Like Receptor 4 Signaling Pathway as a Potential Targets for Stroke-Induced Inflammation
Current Signal Transduction Therapy Biomechanical Stress-induced Signaling in Smooth Muscle Cells: An Update
Current Vascular Pharmacology Plumbagin: A Potential Anti-cancer Compound
Mini-Reviews in Medicinal Chemistry Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects
Current Pharmaceutical Design The Promising Pharmacological Effects and Therapeutic/Medicinal Applications of Punica Granatum L. (Pomegranate) as a Functional Food in Humans and Animals
Recent Patents on Inflammation & Allergy Drug Discovery Selective Binding BAFF/APRIL by the In and Outside Conservative Region of BCMA
Protein & Peptide Letters The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa
Letters in Drug Design & Discovery Subject Index To Volume 6
Infectious Disorders - Drug Targets HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?
Protein & Peptide Letters The Tachykinergic System as Avenues for Drug Intervention
Recent Patents on CNS Drug Discovery (Discontinued) Nutrigenomic Analysis of Diet-Gene Interactions on Functional Supplements for Weight Management
Current Genomics Inflammaging of Female Reproductive System: A Molecular Landscape
Current Aging Science Resveratrol and Stroke: from Chemistry to Medicine
Current Neurovascular Research MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy
Current Gene Therapy Nanoparticles in Melanoma
Current Medicinal Chemistry Gender Difference Response of Male and Female Immunodeficiency Rats Treated with Tissue-specific Biomolecules
Current Pharmaceutical Biotechnology Calcium as a Molecular Target in Angiogenesis
Current Pharmaceutical Design Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters